John Mark O'Mahony - 26 Jan 2024 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Signature
/s/ Douglas E. Onsi, as attorney-in-fact for John Mark O'Mahony
Issuer symbol
LPTX
Transactions as of
26 Jan 2024
Net transactions value
$0
Form type
4
Filing time
30 Jan 2024, 20:41:24 UTC
Previous filing
25 Aug 2023
Next filing
31 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LPTX Common Stock Options Exercise +5,000 5,000 26 Jan 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Restricted Stock Units Options Exercise $0 -5,000 -100% $0.000000* 0 26 Jan 2024 Common Stock 5,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units convert into common stock on a one-for-one basis.
F2 The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.
F3 On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.